查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年北美上游生物加工市场预测 - 区域分析 - 按产品类型、工作流程、使用类型和模式
市场调查报告书
商品编码
1567860

到 2030 年北美上游生物加工市场预测 - 区域分析 - 按产品类型、工作流程、使用类型和模式

North America Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type, Workflow, Usage Type, and Mode
出版日期: | 出版商: The Insight Partners | 英文 127 Pages | 订单完成后即时交付

价格

2022年北美上游生物加工市场价值为39.5862亿美元，预计到2030年将达到106.0338亿美元；预计2022年至2030年复合年增长率为13.1%。

一次性生物反应器的商业用途推动了北美上游生物加工市场。

由于一次性生物反应器 (SUB) 结构坚固且性能优异，许多製造商正在开发一次性生物反应器 (SUB)，这对于生物製药的商业製造是必需的。与生物膜形成、搅拌机制、生物反应器设计和感测器系统等相关技术的结合，导致实验室和生产规模越来越多地采用一次性反应器。一次性生物反应器用于製造下一代细胞和基因疗法，它们适用于连续生物加工。细胞培养过程的进步已经产生了更高的滴度和细胞密度，促进了 SUB 的采用。一次性生物反应器的运作污染风险低，生产週转时间短，验证时间短。在过去几年中，一次性生物反应器在现代生物製药製程中的使用有所增加，因为它们具有帮助提高灵活性、减少投资和限制营运成本的独特能力。此外，许多公司还开发了一次性生物反应器来生产各种治疗药物。 2021 年 3 月，Thermo Fischer Scientific 推出了 3,000 L 和 5,000 L HyPerforma DynaDrive 一次性生物反应器。 Sartorius AG 提供各种一次性生物反应器。该公司提供适用于 10-15 mL 微型生物反应器规模的 ambr 15 和适用于 50-2000L 规模的 Biostat STR。随后，一次性生物反应器在上游生物加工中的使用不断增加。因此，越来越多地接受用于生产治疗药物的一次性生物反应器，推动了上游生物加工市场的发展。

北美上游生物加工市场概况

北美的上游生物加工市场分为美国、加拿大和墨西哥。北美市场的成长归因于生物製药和生物技术公司对生物反应器系统的需求不断增加、市场参与者的显着存在以及学术和研究机构不断加大的研发力度。此外，製药和生物技术公司的研究活动推动了北美上游生物加工市场的成长。

北美上游生物加工市场收入及 2030 年预测（百万美元）

北美上游生物加工市场细分

北美上游生物加工市场根据产品类型、工作流程、使用类型、模式和国家进行细分。

根据产品类型，北美上游生物加工市场分为生物反应器/发酵槽、细胞培养、过滤器、袋子和容器等。 2022 年，生物反应器/发酵器服务占据最大的市场份额。

根据工作流程，北美上游生物加工市场分为培养基製备、细胞培养和细胞分离。 2022 年，细胞分离占据最大的市场份额。

就使用类型而言，北美上游生物加工市场分为一次性和多用途。 2022年一次性使用将占据更大的市场份额

依模式划分，北美上游生物加工市场分为内部和外包。 2022 年，In-house 占据了更大的市场份额。

依国家划分，北美上游生物加工市场分为美国、加拿大和墨西哥。 2022年，美国将主导北美上游生物加工市场。

Thermo Fisher Scientific Inc、Esco Micro Pte Ltd、Sartorius AG、Danaher Corp、Getinge AB、Merck KGaA、Corning Inc、Entegris Inc 和 PBS Biotech Inc 是北美上游生物加工市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美上游生物加工市场格局

  • 概述
  • PEST分析

第 5 章：北美上游生物加工市场 - 主要市场动态

  • 市场驱动因素
    • 一次性生物反应器的商业用途
    • 生物製药製造外包
    • 医药和生技产业快速成长
  • 市场限制
    • 严格的规范架构
  • 市场机会
    • 技术进步
  • 未来趋势
    • 加大生医产业研发投入
  • 驱动因素和限制的影响：

第 6 章：上游生物加工市场 - 北美分析

第 7 章：北美上游生物加工市场分析 - 按产品类型

  • 生物反应器/发酵罐
  • 细胞培养
  • 过滤器
  • 袋子和容器
  • 其他的

第 8 章：北美上游生物加工市场分析 - 按工作流程

  • 媒体准备
  • 细胞培养
  • 细胞分离

第 9 章：北美上游生物加工市场分析 - 按使用类型

  • 一次使用
  • 多用途

第 10 章：北美上游生物加工市场分析 - 按模式

  • 内部
  • 外包

第 11 章：北美上游生物加工市场 - 国家分析

  • 北美市场概况
    • 北美洲
      • 我们
      • 加拿大
      • 墨西哥

第 12 章：产业格局

  • 概述
  • 上游生物加工市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte. Ltd.
  • Sartorius AG
  • Danaher Corp
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris, Inc.
  • PBS Biotech, Inc.

第 14 章：附录

Product Code: BMIRE00030683

The North America upstream bioprocessing market was valued at US$ 3,958.62 million in 2022 and is expected to reach US$ 10,603.38 million by 2030; it is estimated to grow at a CAGR of 13.1% from 2022 to 2030.

Commercial Use of Single-Use Bioreactors Fuels North America Upstream Bioprocessing Market.

Various manufacturers are developing single-use bioreactors (SUBs) due to their robust build and high performance, which are necessary for the commercial manufacturing of biopharmaceuticals. The incorporation of technologies associated with biofilm formation, stirring mechanisms, bioreactor designs, and sensor systems, among others, have resulted in the increased adoption of disposable reactors at the laboratory and production scales. Single-use bioreactors are operated to manufacture next-generation cell and gene therapies, and they are suitable for continuous bioprocessing. Advancements in cell-culture processes have developed higher titers and cell densities, facilitating the adoption of SUBs. Single-use bioreactors operate with a low risk of contamination, shorter production turnaround times, and reduced validation time. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to aid enhanced flexibility, reduce investments, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. In March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors. Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The use of single-use bioreactors is subsequently increasing in upstream bioprocessing. Thus, the increasing acceptance of single-use bioreactors for the production of therapeutics propels the upstream bioprocessing market.

North America Upstream Bioprocessing Market Overview

The upstream bioprocessing market in North America is segmented into the US, Canada, and Mexico. Market growth in North America is attributed to the increasing demand for bioreactor systems from biopharmaceutical and biotechnology companies, the prominent presence of market players, and growing R&D efforts by academic and research institutes. In addition, research activities by pharmaceutical and biotechnology companies propel the upstream bioprocessing market growth in North America.

North America Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

North America Upstream Bioprocessing Market Segmentation

The North America upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country.

Based on product type, the North America upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the North America upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

In terms of usage type, the North America upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022

By mode, the North America upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the North America upstream bioprocessing market is segmented into the US, Canada, and Mexico. The US dominated the North America upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Sartorius AG, Danaher Corp, Getinge AB, Merck KGaA, Corning Inc, Entegris Inc, and PBS Biotech Inc are some of the leading companies operating in the North America upstream bioprocessing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Commercial Use of Single-Use Bioreactors
    • 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements
  • 5.4 Future Trends
    • 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - North America Analysis

7. North America Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Upstream Bioprocessing Market - Country Analysis

  • 11.1 North America Market Overview
    • 11.1.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 US
      • 11.1.1.3 US: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 US: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.3.2 US: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.3.3 US: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.3.4 US: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.4 Canada
      • 11.1.1.5 Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Canada: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.5.2 Canada: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.5.3 Canada: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.5.4 Canada: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.6 Mexico
      • 11.1.1.7 Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 Mexico: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.7.2 Mexico: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.7.3 Mexico: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.7.4 Mexico: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte. Ltd.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Sartorius AG
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Danaher Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Getinge AB
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Merck KGaA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Entegris, Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 PBS Biotech, Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 7. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 8. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 9. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 10. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 11. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 12. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 13. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 14. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 15. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 16. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 17. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 18. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 19. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 20. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
  • Table 21. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Upstream Bioprocessing Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
  • Figure 6. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 13. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 17. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 20. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 25. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. Growth Strategies in Upstream Bioprocessing Market